{"id":"W2343566398","doi":"10.1007/s10549-016-3808-x","title":"Phase II clinical study of eribulin monotherapy in Japanese patients with metastatic breast cancer who had well-defined taxane resistance","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Eisai Canada; Eisai; Ministry of Health, Labour and Welfare; Japan Agency for Medical Research and Development","keywords":"Medicine; Eribulin; Taxane; Internal medicine; Metastatic breast cancer; Tolerability; Breast cancer; Neutropenia; Febrile neutropenia; Clinical endpoint; Gastroenterology; Progressive disease; Adverse effect; Oncology; Surgery; Chemotherapy; Cancer; Clinical trial","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001191216,0.00127229,0.002618271,0.0003536182,0.000427032,0.0004938704,0.0005730985,0.0007092752,0.001822472],"category_scores_gemma":[0.0004963563,0.0004615324,0.0007017075,0.0003915467,0.0007909486,0.0004554021,0.0003182243,0.00134885,0.0003857491],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006404211,"about_ca_system_score_gemma":0.001480411,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001049807,"about_ca_topic_score_gemma":0.003152256,"domain_scores_codex":[0.9996867,0.0001507064,0.00001664912,0.0000497825,0.00002786023,0.00006829386],"domain_scores_gemma":[0.9996269,0.00003382782,0.00005180449,0.00003544117,0.00003118256,0.0002207859],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5681219,0.1149451,0.02383896,0.001122659,0.001835222,0.0008827263,0.0008966114,0.003208391,0.1867445,0.0005045294,0.002995222,0.09490418],"study_design_scores_gemma":[0.2555268,0.699876,0.0311054,0.00003369004,0.0006398362,0.0005499225,0.0001680738,0.001194032,0.006937324,0.0001419089,0.003789384,0.00003770976],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960275,0.00132471,0.0003231782,0.0001006301,0.00003398042,0.001319385,0.0001973001,0.00002502345,0.000648298],"genre_scores_gemma":[0.9920515,0.001690462,0.00142761,0.0004449743,0.00007779812,0.002085499,0.0008723639,0.00001450496,0.001335264],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002618271,"threshold_uncertainty_score":0.006299794,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07258553034229742,"score_gpt":0.4487050927202439,"score_spread":0.3761195623779465,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}